View Older Stories View More Recent Stories

May 30, 2018 07:25AM Arrowhead Pharmaceuticals to Present at Upcoming June 2018 Conferences
May 21, 2018 07:30AM Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis
May 14, 2018 07:34AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Dosing of 1st Hepatitis B Patient in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
May 14, 2018 07:30AM Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
May 11, 2018 07:30AM Arrowhead Pharmaceuticals Presents Preclinical Data on Expanding Cardiometabolic Pipeline
May 8, 2018 04:00PM Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results
May 1, 2018 07:30AM Arrowhead Pharmaceuticals to Present Preclinical Data on Emerging Pipeline of RNAi Therapeutics
Apr 24, 2018 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results
Apr 11, 2018 07:06AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Clinical Data on ARC-520 at International Liver Congress 2018
Apr 11, 2018 07:00AM Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™
Mar 28, 2018 07:32AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Multiple Presentations at The International Liver Congress
Mar 28, 2018 07:30AM Arrowhead Pharmaceuticals Announces Multiple Presentations at The International Liver Congress™
Mar 27, 2018 07:34AM Arrowhead Pharmaceuticals Corp (ARWR) Commences Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Mar 27, 2018 07:30AM Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
Mar 20, 2018 04:05PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Mar 12, 2018 07:30AM Arrowhead Begins Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Mar 6, 2018 07:30AM Arrowhead to Present at Barclays Global Healthcare Conference 2018
Feb 22, 2018 07:34AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Feb 22, 2018 07:30AM Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Feb 15, 2018 01:34PM Arrowhead Pharmaceuticals Corp (ARWR) Confirms Orphan Drug Status for ARO-AAT
Feb 15, 2018 01:32PM Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT
Feb 15, 2018 07:31AM Arrowhead Pharmaceuticals Corp (ARWR) Says it Was Cleared to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B
Feb 15, 2018 07:30AM Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B
Feb 9, 2018 04:00PM Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results
Feb 2, 2018 04:00PM Arrowhead Pharmaceuticals to Webcast Fiscal 2018 First Quarter Results
Dec 27, 2017 04:00PM Arrowhead Pharmaceuticals Corp (ARWR) Appoints William Waddill to Board of Directors
Dec 27, 2017 04:00PM Arrowhead Pharmaceuticals Appoints William Waddill to Board of Directors
Dec 22, 2017 07:33AM Arrowhead Pharmaceuticals Corp (ARWR) Files for Clearance to Start Phase 1/2 Study of ARO-HBV
Dec 22, 2017 07:30AM Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV
Dec 20, 2017 07:31AM Arrowhead Pharmaceuticals Corp (ARWR) Announces Filing of Regulatory Clearance to Begin Phase 1 Study of ARO-AAT
Dec 20, 2017 07:30AM Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-AAT
Dec 18, 2017 06:27PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(C)(4)
Dec 12, 2017 04:00PM Arrowhead Pharmaceuticals Reports Fiscal 2017 Year End Results
Dec 6, 2017 08:46AM Arrowhead (ARWR) Presents New Data Showing Sustained Host Response in HBV Patients Following RNAi Therapy
Dec 6, 2017 07:00AM Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy
Dec 5, 2017 04:00PM Arrowhead Pharmaceuticals to Webcast 2017 Fiscal Year End Results
Nov 14, 2017 07:30AM Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference
Oct 23, 2017 04:30PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Oct 23, 2017 08:07AM Arrowhead Pharmaceuticals Corp (ARWR) Reports Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease
Oct 23, 2017 08:00AM Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting® 2017
Oct 10, 2017 09:30AM Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting®
Oct 3, 2017 04:00PM Arrowhead to Present at Chardan Gene Therapy Conference
Sep 27, 2017 02:00PM Arrowhead Data Reveal Important Considerations for Future Hepatitis B Treatment
Sep 14, 2017 12:00PM Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM™ Platform and Lead RNAi-based Drug Candidates
Sep 11, 2017 04:00PM Arrowhead to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 1, 2017 07:30AM Arrowhead Pharmaceuticals to Host R&D Day on RNAi-Based Therapies
Aug 3, 2017 04:00PM Arrowhead Reports Fiscal 2017 Third Quarter Results
Jul 27, 2017 04:00PM Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results
Jun 9, 2017 04:30PM Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
May 3, 2017 04:00PM Arrowhead Reports Fiscal 2017 Second Quarter Results
View More Recent Stories View Older Stories